Skip To Main Content
Lilly
Menu closed
Lilly
  • Medical Home
  • Medical Education
      • All Therapeutic Areas
        • Alopecia Areata
        • Atopic Dermatitis
        • Psoriasis
        • Diabetes
        • Hypoglycemia
        • Inflammatory Bowel Disease
        • Ulcerative Colitis
        • COVID-19
        • Headache Disorders
        • Neurodegeneration
        • Breast Cancer
        • Hematologic Cancer
        • Axial Spondyloarthritis
        • Psoriatic Arthritis
        • Rheumatoid Arthritis
        • Resources
      • All Therapeutic Areas
        • Alopecia Areata
        • Atopic Dermatitis
        • Psoriasis
        • Diabetes
        • Hypoglycemia
        • Inflammatory Bowel Disease
        • Depression
        • Headache Disorders
        • Breast Cancer
        • Gastrointestinal Cancer
        • Oncology General
        • Osteoporosis
        • Rheumatoid Arthritis
        • Resources
  • Independent Medical Education
      • Alopecia Areata
      • Atopic Dermatitis
      • Psoriasis
    • Diabetes
      • Ulcerative Colitis
      • COVID-19
      • Headache Disorders
      • Neurodegeneration
    • Obesity
      • Breast Cancer
      • Gastrointestinal Cancer
      • Hematologic Cancer
      • Non-small Cell Lung Cancer
      • Prostate Cancer
      • Oncology General
      • Precision Medicine and Diagnostics
      • Axial Spondyloarthritis
      • Systemic Lupus Erythematosus
      • Psoriatic Arthritis
      • Rheumatoid Arthritis
  • Chat Contact Us

Independent Medical Education

Oncology: Breast Cancer

Lilly is committed to supporting high-quality education and QI initiatives that provide healthcare professionals (HCPs) with evidence-based, clinically relevant content that advances learners’ knowledge, competence, and performance in order to ultimately impact patient care. We believe quality education is an excellent source to accelerate evidence into practice for the best interest of HCPs and patients. This site shows independent accredited educational activities supported by Lilly via educational grants and targeted for HCPs. All accredited programs must follow the standards set forth in the ACCME Standards for Integrity and Independence in Accredited Continuing Education. All decisions related to the planning, faculty selection, content creation and delivery of accredited education are the sole responsibility of the providers and/or accreditors. Lilly does not support independent education, or any medical activities, for the purpose of encouraging off-label use of our products.

Because the ACCME Standards prohibit us from providing a direct link to the educational activity, you may have to search within the link using the title of the program.

Management of HR+/HER2- Early Breast Cancer

Video panel discussions, patient case study modules and patient communication guide

Provider: Springer Science + Business Media Finance Inc

Virtual Enduring
28-JAN-2022 to 31-MAR-2023

Individualizing Neo/Adjuvant Treatment in Early Breast Cancer Care: Education, Tools, and Resources for Patients and Providers

5 Microlearning Interactive Text Modules and Decision Support Tools

Provider: Clinical Care Options, LLC

Virtual Enduring
1-FEB-2022 to 15-AUG-2023

Raising the Bar in HR+/HER2- Early Breast Cancer

Webinar with point-of-care practice tools

Provider: PVI, PeerView Institute for Medical Education, Inc.

Virtual Enduring
28-FEB-2022 to 27-FEB-2023

Optimizing Outcomes in HR+/HER2- Breast Cancer: Personalizing Treatment Selection and Patient Management

On-demand Webinar

Provider: TotalCME, Inc.

Virtual Enduring
1-MAR-2022 to 1-MAR-2023

Optimal Utilization of Ki67 Testing in HR-Positive/HER2-Negative Early Breast Cancer: Education and Resources for the Oncology and Pathology Healthcare Teams

Webinar with point-of-care practice tools; developed in partnership with American Society for Clinical Pathology

Provider: Clinical Care Options, LLC

Virtual Enduring
4-MAR-2022 to 10-MAY-2023

New horizons in high-risk HR+ HER2 - EBC

Video panel discussion

Provider: USF Health Professions Conferencing Corporation

Virtual Enduring
28-MAR-2022 to 28-MAR-2023

How can shared decision-making be successfully integrated to optimize care of patients with high-risk early breast cancer?

6- Tweetorials - this is incorrect - Should be Multidisciplinary team video panel discussion

Provider: USF Health Professions Conferencing Corporation

Virtual Enduring
8-JUN-2022 to 8-JUN-2023

A Nurses’ Perspective: Oral Therapies in Breast Cancer: Considerations for Enhanced Adherence in the Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2-negative Breast Cancer

Webinar - recording of Oncology Nurses Quality (ONQ) Virtual Meeting Series

Provider: UMA MLG, LLC

Virtual Enduring
15-APR-2022 to 15-APR-2023

Best Practices for the Implementation of Clinical Advances in HR-Positive/HER2-Negative Breast Cancer

Webinar Video Symposium Proceedings from 2022 HOPA Annual Conference

Provider: ProCE LLC

Virtual Enduring
22-APR-2022 to 21-APR-2023

What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation in Breast Cancer

Webinar Video Symposium Proceedings from 2022 ONS Annual Congress

Provider: Research to Practice

Virtual Enduring
29-MAY-2022 to 29-MAY-2023

Testing and Utilization of Ki67 and Other Prognostic Markers for Clinical Decision Making in HR-Positive, HER2-Negative Breast Cancer

Community Practice Connection - Symposium proceedings from 2022 U.S. & Canadian Academy of Pathology annual Meeting

Provider: Physicians' Education Resource LLC

Virtual Enduring
30-MAY-2022 to 30-MAY-2023

Individualizing Therapy for High-Risk Early-Stage Hormone Receptor-Positive Breast Cancer: An Expert Tumor Board Discussion

Webinar Video Symposium Proceedings from 2022 Miami Breast Cancer Conference

Provider: Physicians' Education Resource LLC

Virtual Enduring
30-MAY-2022 to 30-MAY-2023

Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice

Webinar Video Symposium Proceedings from 2022 ESMO Congress

Provider: Answers in CME Inc.

Virtual Enduring
15-JUN-2022 to 14-JUN-2023

From Biomarkers to Treatment: The New Need-to-Know in Early Breast Cancer

Webinar Video Symposium Proceedings from 2022 ASCO Annual Meeting

Provider: Clinical Care Options, LLC

Virtual Enduring
29-JUN-2022 to 30-JUL-2023

Evaluation and treatment of patients with early HR+/HER2 breast cancer: a clinical case

Patient case video simulation

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
30-JUN-2022 to 1-APR-2023

Navigating Adjuvant Therapy Decision-Making for High-Risk Early-Stage Hormone Receptor-Positive Breast Cancer: An Expert Tumor Board Discussion

Webinar Video Symposium Proceedings from 2022 American Society of Breast Surgeons Annual Meeting

Provider: Physicians' Education Resource LLC

Virtual Enduring
30-JUN-2022 to 30-JUN-2023

Beyond The Guidelines: Clinical Investigator Perspectives on the Management of Patients with Breast Cancer

Webinar Video Symposium Proceedings from 2022 ASCO Annual Meeting

Provider: Research to Practice

Virtual Enduring
5-JUL-2022 to 5-JUL-2023

Improving Adherence to Oral Oncolytics in Breast Cancer: The Pivotal Role of Nurse Navigators

Webinar Video Symposium Proceedings from Academy of Oncology Nurse & Patient Navigators (AONN+) 2022 Midyear Conference

Provider: AKH Inc., Advancing Knowledge in Healthcare

Virtual Enduring
25-JUL-2022 to 24-JUL-2023

Improving Adherence to Oral Oncolytics in Breast Cancer: The Pivotal Role of Nurse Navigators

CE Monograph

Provider: AKH Inc., Advancing Knowledge in Healthcare

Enduring - Hard Copy Materials
28-NOV-2022 to 27-NOV-2023

Expanding the Scope of Precision Care for Patients With HR-Positive Breast Cancers: Things You Should Know

Webinar Video Symposium Proceedings from 2022 ASCO Annual Meeting

Provider: Clinical Care Options, LLC

Virtual Enduring
31-JUL-2022 to 30-JUL-2023

Recent Advances and Real-World Implications in Medical Oncology: A Daylong Multitumor Educational Symposium in Partnership with the North Carolina Oncology Association and the South Carolina Oncology Society

Webinar Video Symposium Proceedings from 2022 AON Annual Meeting (see Multitumor Symposia Proceedings)

Provider: Research to Practice

Virtual Enduring
7-SEP-2022 to 7-SEP-2023

Breaking Down Barriers to Treatment Adherence & Persistence in HR+ HER2- EBC: Team-Based Strategies for Improved Adverse Event Monitoring & Management, Treatment Plan Modifications, & Shared Decision-Making

Video-Based/Interactive inExchange Activity

Provider: PVI, PeerView Institute for Medical Education, Inc.

Virtual Enduring
9-SEP-2022 to 8-SEP-2023

Adjuvant Therapies in HR+/HER2- Early Breast Cancer: A 3-Step Plan to Improve Adherence and Persistence

3-part webinar with point-of-care practice tools

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
22-SEP-2022 to 22-SEP-2023

HR+/HER2- Early Breast Cancer: A Nurse Clinic on Monitoring and Communicating With Patients

On-demand Webinar

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
26-SEP-2022 to 26-SEP-2023

Cases From the Clinics: The Nurse's Role in Communicating on Adherence and Persistence in Hormone Receptor-Positive, HER2-Negative Early Breast Cancer

On-demand Webinar

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
20-DEC-2022 to 20-DEC-2023

CDK4/6 Inhibitors in HR+/HER2- Breast Cancer: Addressing Barriers to Their Optimal Use

Patient simulation

Provider: Practicing Clinicians Exchange, LLC

Virtual Enduring
25-SEP-2022 to 24-SEP-2023

Improving Outcomes in Patients With High-Risk HR-Positive/HER2-Negative Early Breast Cancer: Keeping the Patient Central

Webinar Video Symposium Proceedings from 2022 ESMO Congress

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
10-OCT-2022 to 10-OCT-2023

Addressing Challenges in Oral Therapies for HR+, HER2- Breast Cancer

On-demand webinar including infographics, point-of-care tool and suggested readings

Provider: Catalyst Medical Education, LLC

Virtual Enduring
31-OCT-2022 to 31-OCT-2023

Assessing Risk in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: How to Approach Challenging Cases in the Clinic

5 Video Expert Commentaries

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
10-NOV-2022 to 10-NOV-2023

The Patient Journey in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Best Practices for Communication and Shared Decision-making

Collection of 5- to 7-minute Video Chapters with Synchronized Slides

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
21-NOV-2022 to 21-NOV-2023

Improving Outcomes for Patients With High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Education and Resources for the Multidisciplinary Team

On-demand Webcast, Podcast, and Video

Provider: Clinical Care Options, LLC

Virtual Enduring
15-NOV-2022 to 14-MAR-2024

The Clinical Implications of Key Recent Data Sets in Oncology: A Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists

Online Multimedia Resource

Provider: Research to Practice

Virtual Enduring
28-NOV-2022 to 28-NOV-2023

Perspectives in Breast Cancer Care

Online Educational Sessions Delivered as Individual Chapters

Provider: WebMD Health Corp. - Medscape LLC

Virtual Enduring
30-NOV-2022 to 30-NOV-2023

Advancing Care for HR+/HER2- Breast Cancer: Managing Patients With CDK4/6 Inhibitors

On-Demand Multimedia Interactive eCourse

Provider: Practicing Clinicians Exchange, LLC

Virtual Enduring
30-NOV-2022 to 30-JAN-2024

Conference Highlights of the 2022 SABCS Annual Meeting

Microlearning Program with Expert Commentary, Online Activity with Polling and Embedded Slides, and Downloadable Slideset

Provider: Clinical Care Options, LLC

Virtual Enduring
5-DEC-2022 to 23-FEB-2024

Clinical Updates From San Antonio

Twitter-Based Clinical Updates

Provider: Integrity Continuing Education, Inc.

Virtual Enduring
13-DEC-2022 to 17-MAR-2023

Precision Medicine Advances in Early Breast Cancer: Experts Discuss the Expanding Role of Biomarkers to Guide Neo/Adjuvant Therapy

On-Demand CME/ABIM MOC-Certified Webcast Recording of Symposium

Provider: Clinical Care Options, LLC

Virtual Enduring
11-JAN-2023 to 10-MAR-2024

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of ER-Positive Breast Cancer

On-demand webcast from SABCS symposium

Provider: Research to Practice

Virtual Enduring
12-JAN-2023 to 12-JAN-2024

NCCN 2023 Breast Cancer Congress with Updates from the 2022 San Antonio Breast Cancer Symposium

Live In-person and Virtual Activity

Provider: National Comprehensive Cancer Network, Inc.

In-Person: Satellite Symposium
3-FEB-2023

PER® 2023 MBCC ISS: Identifying and Mitigating Disparities in Breast Cancer Care: Improving Diagnostics, Trial Access and Care for All Patients

Live Satellite Symposium with Online Enduring Activity

Provider: Physicians' Education Resource LLC

In-Person: Satellite Symposium
3-MAR-2023


  • Copyright
  • Terms of Use
  • Privacy Statement
  • Accessibility Statement
  • Sitemap

To speak to customer support:
Call (XXX) XXX-XXXX

This site is intended for US Healthcare Professionals only.

4.1.3 01/2023 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2023. All rights reserved.

Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

Facebook Twitter
Lilly